{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:08:34Z","timestamp":1789456114539,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Qingdao Key Clinical Specialty Elite Discipline"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05700-y","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T14:34:27Z","timestamp":1785594867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated multi-omic and functional profiling reveals a ZDHHC16-associated palmitoylation-proteostasis state in hepatocellular carcinoma"],"prefix":"10.1007","volume":"17","author":[{"given":"Lihua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchi","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9817-1857","authenticated-orcid":false,"given":"Wensheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"issue":"3","key":"5700_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"5700_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6. https:\/\/doi.org\/10.1038\/s41572-020-00240-3.","journal-title":"Nat Rev Dis Primers"},{"issue":"20","key":"5700_CR3","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, Kudo M, Breder V, Merle P, Kaseb AO, Li D, Verret W, Xu DZ, Hernandez S, Liu J, Huang C, Mulla S, Wang Y, Lim HY, Zhu AX, Cheng AL. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med. 2020;382(20):1894\u2013905. https:\/\/doi.org\/10.1056\/NEJMoa1915745.","journal-title":"N Engl J Med"},{"issue":"4","key":"5700_CR4","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","volume":"76","author":"AL Cheng","year":"2022","unstructured":"Cheng AL, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, Lim HY, Kudo M, Breder V, Merle P, Kaseb AO, Li D, Verret W, Ma N, Nicholas A, Wang Y, Li L, Zhu AX, Finn RS. Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma. J Hepatol. 2022;76(4):862\u201373. https:\/\/doi.org\/10.1016\/j.jhep.2021.11.030.","journal-title":"J Hepatol"},{"issue":"8","key":"5700_CR5","doi-asserted-by":"publisher","first-page":"EVIDoa2100070","DOI":"10.1056\/EVIDoa2100070","volume":"1","author":"GK Abou-Alfa","year":"2022","unstructured":"Abou-Alfa GK, Lau G, Kudo M, Chan SL, Kelley RK, Furuse J, Sukeepaisarnjaroen W, Kang YK, Van Dao T, De Toni EN, Rimassa L, Breder V, Vasilyev A, Heurgu\u00e9 A, Tam VC, Mody K, Thungappa SC, Ostapenko Y, Yau T, Azevedo S, Varela M, Cheng AL, Qin S, Galle PR, Ali S, Marcovitz M, Makowsky M, He P, Kurland JF, Negro A, Sangro B. Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma. NEJM Evid. 2022;1(8):EVIDoa2100070. https:\/\/doi.org\/10.1056\/EVIDoa2100070.","journal-title":"NEJM Evid"},{"issue":"15","key":"5700_CR6","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1200\/jco.23.02745","volume":"42","author":"JD Gordan","year":"2024","unstructured":"Gordan JD, Kennedy EB, Abou-Alfa GK, Beal E, Finn RS, Gade TP, Goff L, Gupta S, Guy J, Hoang HT, Iyer R, Jaiyesimi I, Jhawer M, Karippot A, Kaseb AO, Kelley RK, Kortmansky J, Leaf A, Remak WM, Sohal DPS, Taddei TH, Wilson Woods A, Yarchoan M, Rose MG. Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update. J Clin Oncol. 2024;42(15):1830\u201350. https:\/\/doi.org\/10.1200\/jco.23.02745.","journal-title":"J Clin Oncol"},{"issue":"3","key":"5700_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","volume":"19","author":"JM Llovet","year":"2022","unstructured":"Llovet JM, Castet F, Heikenwalder M, Maini MK, Mazzaferro V, Pinato DJ, Pikarsky E, Zhu AX, Finn RS. Immunotherapies for hepatocellular carcinoma. Nat Rev Clin Oncol. 2022;19(3):151\u201372. https:\/\/doi.org\/10.1038\/s41571-021-00573-2.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"5700_CR8","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41580-024-00700-8","volume":"25","author":"FS Mesquita","year":"2024","unstructured":"Mesquita FS, Abrami L, Linder ME, Bamji SX, Dickinson BC, van der Goot FG. Mechanisms and functions of protein S-acylation. Nat Rev Mol Cell Biol. 2024;25(6):488\u2013509. https:\/\/doi.org\/10.1038\/s41580-024-00700-8.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"5700_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41568-024-00666-x","volume":"24","author":"EW Tate","year":"2024","unstructured":"Tate EW, Soday L, de la Lastra AL, Wang M, Lin H. Protein lipidation in cancer: mechanisms, dysregulation and emerging drug targets. Nat Rev Cancer. 2024;24(4):240\u201360. https:\/\/doi.org\/10.1038\/s41568-024-00666-x.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"5700_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1152\/physrev.00032.2014","volume":"95","author":"LH Chamberlain","year":"2015","unstructured":"Chamberlain LH, Shipston MJ. The physiology of protein S-acylation. Physiol Rev. 2015;95(2):341\u201376. https:\/\/doi.org\/10.1152\/physrev.00032.2014.","journal-title":"Physiol Rev"},{"issue":"11","key":"5700_CR11","doi-asserted-by":"publisher","first-page":"114962","DOI":"10.1016\/j.celrep.2024.114962","volume":"43","author":"M Wu","year":"2024","unstructured":"Wu M, Zhou X, Zhou X, Wang G, Zeng Y, Li J, Prochownik EV, Wang F, Li Y. ZDHHC3-mediated SCAP S-acylation promotes cholesterol biosynthesis and tumor immune escape in hepatocellular carcinoma. Cell Rep. 2024;43(11):114962. https:\/\/doi.org\/10.1016\/j.celrep.2024.114962.","journal-title":"Cell Rep"},{"issue":"40","key":"5700_CR12","doi-asserted-by":"publisher","first-page":"e05702","DOI":"10.1002\/advs.202505702","volume":"12","author":"X Jin","year":"2025","unstructured":"Jin X, Hong Y, Zhao Y, Shi W, Liu R, You X, Yang C, Zhang Y. ZDHHC12 Palmitoylates HDAC8 to Promote the Progression of Hepatocellular Carcinoma Associated with a Diet High in Saturated Fatty Acids. Adv Sci (Weinh). 2025;12(40):e05702. https:\/\/doi.org\/10.1002\/advs.202505702.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"5700_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s12672-026-04538-8","volume":"17","author":"H Zhang","year":"2026","unstructured":"Zhang H, Su H, Xia K, Wang H, Wu Y, Xiong Y, Deng T, Du P. Construction of a prognostic model and multidimensional analysis of hepatocellular carcinoma based on palmitoylation-related genes. Discov Oncol. 2026;17(1):230. https:\/\/doi.org\/10.1007\/s12672-026-04538-8.","journal-title":"Discov Oncol"},{"issue":"1","key":"5700_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12867-016-0065-9","volume":"17","author":"N Cao","year":"2016","unstructured":"Cao N, Li JK, Rao YQ, Liu H, Wu J, Li B, Zhao P, Zeng L, Li J. A potential role for protein palmitoylation and zDHHC16 in DNA damage response. BMC Mol Biol. 2016;17(1):12. https:\/\/doi.org\/10.1186\/s12867-016-0065-9.","journal-title":"BMC Mol Biol"},{"key":"5700_CR15","doi-asserted-by":"publisher","first-page":"e27826","DOI":"10.7554\/eLife.27826","volume":"6","author":"L Abrami","year":"2017","unstructured":"Abrami L, Dallavilla T, Sandoz PA, Demir M, Kunz B, Savoglidis G, Hatzimanikatis V, van der Goot FG. Identification and dynamics of the human ZDHHC16-ZDHHC6 palmitoylation cascade. Elife. 2017;6:e27826. https:\/\/doi.org\/10.7554\/eLife.27826.","journal-title":"Elife"},{"issue":"3","key":"5700_CR16","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.ijrobp.2022.02.018","volume":"113","author":"X Fan","year":"2022","unstructured":"Fan X, Sun S, Yang H, Ma H, Zhao C, Niu W, Fan J, Fang Z, Chen X. SETD2 Palmitoylation Mediated by ZDHHC16 in Epidermal Growth Factor Receptor-Mutated Glioblastoma Promotes Ionizing Radiation-Induced DNA Damage. Int J Radiat Oncol Biol Phys. 2022;113(3):648\u201360. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.02.018.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5700_CR17","doi-asserted-by":"publisher","unstructured":"Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee AV, Omberg L, Wolf DM, Shriver CD, Thorsson V, Hu H. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173(2):400\u2013416.e11. https:\/\/doi.org\/10.1016\/j.cell.2018.02.052.\u00a0","DOI":"10.1016\/j.cell.2018.02.052"},{"issue":"5","key":"5700_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.annonc.2025.02.006","volume":"36","author":"A Vogel","year":"2025","unstructured":"Vogel A, Chan SL, Dawson LA, Kelley RK, Llovet JM, Meyer T, Ricke J, Rimassa L, Sapisochin G, Vilgrain V, Zucman-Rossi J, Ducreux M. Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2025;36(5):491\u2013506. https:\/\/doi.org\/10.1016\/j.annonc.2025.02.006.","journal-title":"Ann Oncol"},{"issue":"6","key":"5700_CR19","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/hep.0000000000000466","volume":"78","author":"AG Singal","year":"2023","unstructured":"Singal AG, Llovet JM, Yarchoan M, Mehta N, Heimbach JK, Dawson LA, Jou JH, Kulik LM, Agopian VG, Marrero JA, Mendiratta-Lala M, Brown DB, Rilling WS, Goyal L, Wei AC, Taddei TH. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023;78(6):1922\u201365. https:\/\/doi.org\/10.1097\/hep.0000000000000466.","journal-title":"Hepatology"},{"issue":"10408","key":"5700_CR20","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/s0140-6736(23)00961-3","volume":"402","author":"S Qin","year":"2023","unstructured":"Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Cheng Y, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Osypchuk Y, Sinielnikov I, Yang TS, Liang X, Chen C, Wang L, Cheng AL, Kaseb A, Vogel A. Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study. Lancet. 2023;402(10408):1133\u201346. https:\/\/doi.org\/10.1016\/s0140-6736(23)00961-3.","journal-title":"Lancet"},{"issue":"12","key":"5700_CR21","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/s1470-2045(23)00469-2","volume":"24","author":"JM Llovet","year":"2023","unstructured":"Llovet JM, Kudo M, Merle P, Meyer T, Qin S, Ikeda M, Xu R, Edeline J, Ryoo BY, Ren Z, Masi G, Kwiatkowski M, Lim HY, Kim JH, Breder V, Kumada H, Cheng AL, Galle PR, Kaneko S, Wang A, Mody K, Dutcus C, Dubrovsky L, Siegel AB, Finn RS. Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial. Lancet Oncol. 2023;24(12):1399\u2013410. https:\/\/doi.org\/10.1016\/s1470-2045(23)00469-2.","journal-title":"Lancet Oncol"},{"issue":"10126","key":"5700_CR22","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/s0140-6736(18)30207-1","volume":"391","author":"M Kudo","year":"2018","unstructured":"Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Piscaglia F, Baron A, Park JW, Han G, Jassem J, Blanc JF, Vogel A, Komov D, Evans TRJ, Lopez C, Dutcus C, Guo M, Saito K, Kraljevic S, Tamai T, Ren M, Cheng AL. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet. 2018;391(10126):1163\u201373. https:\/\/doi.org\/10.1016\/s0140-6736(18)30207-1.","journal-title":"Lancet"},{"key":"5700_CR23","doi-asserted-by":"publisher","unstructured":"Cancer Genome Atlas Research Network. Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell. 2017;169(7):1327\u20131341.e23. https:\/\/doi.org\/10.1016\/j.cell.2017.05.046.","DOI":"10.1016\/j.cell.2017.05.046"},{"issue":"3","key":"5700_CR24","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1053\/j.gastro.2017.06.007","volume":"153","author":"D Sia","year":"2017","unstructured":"Sia D, Jiao Y, Martinez-Quetglas I, Kuchuk O, Villacorta-Martin C, Castro de Moura M, Putra J, Camprecios G, Bassaganyas L, Akers N, Losic B, Waxman S, Thung SN, Mazzaferro V, Esteller M, Friedman SL, Schwartz M, Villanueva A, Llovet JM. Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features. Gastroenterology. 2017;153(3):812\u201326. https:\/\/doi.org\/10.1053\/j.gastro.2017.06.007.","journal-title":"Gastroenterology"},{"issue":"4","key":"5700_CR25","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ccell.2019.08.007","volume":"36","author":"L Ma","year":"2019","unstructured":"Ma L, Hernandez MO, Zhao Y, Mehta M, Tran B, Kelly M, Rae Z, Hernandez JM, Davis JL, Martin SP, Kleiner DE, Hewitt SM, Ylaya K, Wood BJ, Greten TF, Wang XW. Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer. Cancer Cell. 2019;36(4):418\u2013430.e6. https:\/\/doi.org\/10.1016\/j.ccell.2019.08.007.","journal-title":"Cancer Cell"},{"issue":"4","key":"5700_CR26","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","volume":"179","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, He Y, Luo N, Patel SJ, Han Y, Gao R, Modak M, Carotta S, Haslinger C, Kind D, Peet GW, Zhong G, Lu S, Zhu W, Mao Y, Xiao M, Bergmann M, Hu X, Kerkar SP, Vogt AB, Pflanz S, Liu K, Peng J, Ren X, Zhang Z. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell. 2019;179(4):829\u2013845.e20. https:\/\/doi.org\/10.1016\/j.cell.2019.10.003.","journal-title":"Cell"},{"issue":"1","key":"5700_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nrm2084","volume":"8","author":"ME Linder","year":"2007","unstructured":"Linder ME, Deschenes RJ. Palmitoylation: policing protein stability and traffic. Nat Rev Mol Cell Biol. 2007;8(1):74\u201384. https:\/\/doi.org\/10.1038\/nrm2084.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"5700_CR28","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/febs.15781","volume":"289","author":"A Main","year":"2022","unstructured":"Main A, Fuller W. Protein S-Palmitoylation: advances and challenges in studying a therapeutically important lipid modification. Febs J. 2022;289(4):861\u2013882. https:\/\/doi.org\/10.1111\/febs.15781.","journal-title":"Febs j"},{"issue":"4","key":"5700_CR29","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1080\/10409238.2018.1488804","volume":"53","author":"ME Zaballa","year":"2018","unstructured":"Zaballa ME, van der Goot FG. The molecular era of protein S-acylation: spotlight on structure, mechanisms, and dynamics. Crit Rev Biochem Mol Biol. 2018;53(4):420\u201351. https:\/\/doi.org\/10.1080\/10409238.2018.1488804.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"5700_CR30","doi-asserted-by":"publisher","first-page":"116810","DOI":"10.1016\/j.bcp.2025.116810","volume":"234","author":"Z Zhu","year":"2025","unstructured":"Zhu Z, Feng S, Zeng A, Song L. Advances in Palmitoylation: A key Regulator of liver cancer development and therapeutic targets. Biochem Pharmacol. 2025;234:116810. https:\/\/doi.org\/10.1016\/j.bcp.2025.116810.","journal-title":"Biochem Pharmacol"},{"key":"5700_CR31","doi-asserted-by":"publisher","unstructured":"Qian YR, Zhao YJ, Zhang F. Protein palmitoylation: biological functions, disease, and therapeutic targets. MedComm (2020). 2025;6(3):e70096. https:\/\/doi.org\/10.1002\/mco2.70096.","DOI":"10.1002\/mco2.70096"},{"issue":"7","key":"5700_CR32","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-019-0101-y","volume":"20","author":"MS Hipp","year":"2019","unstructured":"Hipp MS, Kasturi P, Hartl FU. The proteostasis network and its decline in ageing. Nat Rev Mol Cell Biol. 2019;20(7):421\u201335. https:\/\/doi.org\/10.1038\/s41580-019-0101-y.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"5700_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1878-0261.13308","volume":"17","author":"B Zhou","year":"2023","unstructured":"Zhou B, Hao Q, Liang Y, Kong E. Protein palmitoylation in cancer: molecular functions and therapeutic potential. Mol Oncol. 2023;17(1):3\u201326. https:\/\/doi.org\/10.1002\/1878-0261.13308.","journal-title":"Mol Oncol"},{"issue":"1","key":"5700_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.Cd-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12(1):31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-1059.","journal-title":"Cancer Discov"},{"issue":"43","key":"5700_CR35","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350. https:\/\/doi.org\/10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5700_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.12688\/f1000research.6464.1","volume":"4","author":"M Blanc","year":"2015","unstructured":"Blanc M, David F, Abrami L, Migliozzi D, Armand F, B\u00fcrgi J, van der Goot FG. SwissPalm: Protein Palmitoylation database. F1000Res. 2015;4:261. https:\/\/doi.org\/10.12688\/f1000research.6464.1.","journal-title":"F1000Res"},{"issue":"1","key":"5700_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13046-017-0670-6","volume":"37","author":"S Chen","year":"2018","unstructured":"Chen S, Pu J, Bai J, Yin Y, Wu K, Wang J, Shuai X, Gao J, Tao K, Wang G, Li H. EZH2 promotes hepatocellular carcinoma progression through modulating miR-22\/galectin-9 axis. J Exp Clin Cancer Res. 2018;37(1):3. https:\/\/doi.org\/10.1186\/s13046-017-0670-6.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"5700_CR38","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s40425-019-0784-9","volume":"7","author":"G Xiao","year":"2019","unstructured":"Xiao G, Jin LL, Liu CQ, Wang YC, Meng YM, Zhou ZG, Chen J, Yu XJ, Zhang YJ, Xu J, Zheng L. EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma. J Immunother Cancer. 2019;7(1):300. https:\/\/doi.org\/10.1186\/s40425-019-0784-9.","journal-title":"J Immunother Cancer"},{"issue":"3","key":"5700_CR39","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1152\/physrev.00028.2012","volume":"93","author":"T Balla","year":"2013","unstructured":"Balla T. Phosphoinositides: tiny lipids with giant impact on cell regulation. Physiol Rev. 2013;93(3):1019\u2013137. https:\/\/doi.org\/10.1152\/physrev.00028.2012.","journal-title":"Physiol Rev"},{"issue":"7","key":"5700_CR40","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","volume":"169","author":"C Zheng","year":"2017","unstructured":"Zheng C, Zheng L, Yoo JK, Guo H, Zhang Y, Guo X, Kang B, Hu R, Huang JY, Zhang Q, Liu Z, Dong M, Hu X, Ouyang W, Peng J, Zhang Z. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing. Cell. 2017;169(7):1342\u20131356.e16. https:\/\/doi.org\/10.1016\/j.cell.2017.05.035.","journal-title":"Cell"},{"issue":"1","key":"5700_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39(1):1\u201310. https:\/\/doi.org\/10.1016\/j.immuni.2013.07.012.","journal-title":"Immunity"},{"issue":"1","key":"5700_CR42","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, Hackl H, Trajanoski Z. Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade. Cell Rep. 2017;18(1):248\u201362. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.019.","journal-title":"Cell Rep"},{"issue":"10","key":"5700_CR43","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, Li Z, Traugh N, Bu X, Li B, Liu J, Freeman GJ, Brown MA, Wucherpfennig KW, Liu XS. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138. https:\/\/doi.org\/10.1038\/s41591-018-0136-1.","journal-title":"Nat Med"},{"issue":"3","key":"5700_CR44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3892\/ijmm.2026.5729","volume":"57","author":"XM Chen","year":"2026","unstructured":"Chen XM, Liang YB, Zuo JX, Yang ZS, Zhang LY, Zhang XY, Wan P, Ke Y. ZG16B: A key regulator of tumor progression and immune microenvironment modulation in cancer (Review). Int J Mol Med. 2026;57(3):58. https:\/\/doi.org\/10.3892\/ijmm.2026.5729.","journal-title":"Int J Mol Med"},{"issue":"8","key":"5700_CR45","doi-asserted-by":"publisher","first-page":"928","DOI":"10.20892\/j.issn.2095-3941.2025.0150","volume":"22","author":"J Xiang","year":"2025","unstructured":"Xiang J, Li Y, Mei S, Ou Z, Wang L, Ke Y, Li Z. Novel diagnostic and therapeutic strategies based on PANoptosis for hepatocellular carcinoma. Cancer Biol Med. 2025;22(8):928\u201339. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2025.0150.","journal-title":"Cancer Biol Med"},{"issue":"Database issue","key":"5700_CR46","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, Bindal N, Beare D, Smith JA, Thompson IR, Ramaswamy S, Futreal PA, Haber DA, Stratton MR, Benes C, McDermott U, Garnett MJ. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41(Database issue):D955\u201361. https:\/\/doi.org\/10.1093\/nar\/gks1111.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"5700_CR47","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","volume":"166","author":"F Iorio","year":"2016","unstructured":"Iorio F, Knijnenburg TA, Vis DJ, Bignell GR, Menden MP, Schubert M, Aben N, Gon\u00e7alves E, Barthorpe S, Lightfoot H, Cokelaer T, Greninger P, van Dyk E, Chang H, de Silva H, Heyn H, Deng X, Egan RK, Liu Q, Mironenko T, Mitropoulos X, Richardson L, Wang J, Zhang T, Moran S, Sayols S, Soleimani M, Tamborero D, Lopez-Bigas N, Ross-Macdonald P, Esteller M, Gray NS, Haber DA, Stratton MR, Benes CH, Wessels LFA, Saez-Rodriguez J, McDermott U, Garnett MJ. A Landscape of Pharmacogenomic Interactions in Cancer. Cell. 2016;166(3):740\u201354. https:\/\/doi.org\/10.1016\/j.cell.2016.06.017.","journal-title":"Cell"},{"issue":"7757","key":"5700_CR48","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi M, Huang FW, Jan\u00e9-Valbuena J, Kryukov GV, Lo CC, McDonald ER 3rd, Barretina J, Gelfand ET, Bielski CM, Li H, Hu K, Andreev-Drakhlin AY, Kim J, Hess JM, Haas BJ, Aguet F, Weir BA, Rothberg MV, Paolella BR, Lawrence MS, Akbani R, Lu Y, Tiv HL, Gokhale PC, de Weck A, Mansour AA, Oh C, Shih J, Hadi K, Rosen Y, Bistline J, Venkatesan K, Reddy A, Sonkin D, Liu M, Lehar J, Korn JM, Porter DA, Jones MD, Golji J, Caponigro G, Taylor JE, Dunning CM, Creech AL, Warren AC, McFarland JM, Zamanighomi M, Kauffmann A, Stransky N, Imielinski M, Maruvka YE, Cherniack AD, Tsherniak A, Vazquez F, Jaffe JD, Lane AA, Weinstock DM, Johannessen CM, Morrissey MP, Stegmeier F, Schlegel R, Hahn WC, Getz G, Mills GB, Boehm JS, Golub TR, Garraway LA, Sellers WR. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature. 2019;569(7757):503\u20138. https:\/\/doi.org\/10.1038\/s41586-019-1186-3.","journal-title":"Nature"},{"issue":"7603","key":"5700_CR49","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature17987","volume":"533","author":"PM Haverty","year":"2016","unstructured":"Haverty PM, Lin E, Tan J, Yu Y, Lam B, Lianoglou S, Neve RM, Martin S, Settleman J, Yauch RL, Bourgon R. Reproducible pharmacogenomic profiling of cancer cell line panels. Nature. 2016;533(7603):333\u20137. https:\/\/doi.org\/10.1038\/nature17987.","journal-title":"Nature"},{"key":"5700_CR50","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.2147\/jhc.S544589","volume":"12","author":"QB Wang","year":"2025","unstructured":"Wang QB, Luo WL, Li YK, Li J, Yang ZS, Zhao K, Lakang Y, Liang YB, Chen XM, Zuo JX, Duan Y, Xu X, Shang LM, Ke Y. Tumor Compression of the Hepatic or Portal Vein Predicts the Presence of Microvascular Invasion and Satellite Nodules in Hepatocellular Carcinoma: A Retrospective Study. J Hepatocell Carcinoma. 2025;12:2055\u201367. https:\/\/doi.org\/10.2147\/jhc.S544589.","journal-title":"J Hepatocell Carcinoma"},{"key":"5700_CR51","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.2147\/jhc.S556306","volume":"12","author":"WL Luo","year":"2025","unstructured":"Luo WL, Wang QB, Li YK, Liang YB, Li J, Chen XM, Lakang Y, Yang ZS, Zuo JX, Wang W, Li SX, Ke Y. Impact of Middle Hepatic Vein Resection During Hemihepatectomy on Surgical Outcomes and Long-Term Prognosis in Hepatocellular Carcinoma: A Retrospective Study. J Hepatocell Carcinoma. 2025;12:2681\u201392. https:\/\/doi.org\/10.2147\/jhc.S556306.","journal-title":"J Hepatocell Carcinoma"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05700-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05700-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05700-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:27:20Z","timestamp":1789453640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05700-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5700"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05700-y","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]},"assertion":[{"value":"15 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study did not enroll human participants, use human tissue specimens, or involve animal experiments. All human-related data were obtained from publicly available, de-identified databases, and the experimental component was limited to established HCC cell lines. No human participants were recruited or directly involved in this study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This manuscript does not contain identifiable personal information, images, or other individual-level material requiring consent for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1333"}}